1a2y:A (ASP1) to (ILE106) HEN EGG WHITE LYSOZYME, D18A MUTANT, IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3 | COMPLEX (IMMUNOGLOBULIN/HYDROLASE), IMMUNOGLOBULIN V REGION, SIGNAL, HYDROLASE, GLYCOSIDASE, BACTERIOLYTIC ENZYME, EGG WHITE
1a4k:L (GLU1) to (ILE106) DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
1a4k:A (GLU1) to (ILE106) DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
1nby:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A | ANTIBODY, LYSOZYME, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
1nbz:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A | ANTIBODY, LYSOZYME, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
3rnq:A (SER34) to (THR145) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND PD-L2 | PD-1-MUTANT, PD-L2; B7-DC; PROGRAMMED DEATH-1 LIGAND 2, COMPLEX, COSTIMULATORY, IMMUNE SYSTEM
1a7o:L (ASP1) to (ILE106) FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) R96L DELETION MUTANT ON VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL | IMMUNOGLOBULIN, VARIANT, DELETION MUTANT
1nez:H (GLU6) to (GLN120) THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION, CO-RECEPTOR PREFERENCE AND AFFINITY | IMMUNE SYSTEM
2arj:R (ALA4) to (LEU119) CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB | PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
2arj:Q (ALA4) to (LEU119) CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB | PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN
1ngx:A (LEU2) to (ILE106) CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND | ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM
1ngx:L (LEU2) to (ILE106) CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND | ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM
2ojz:L (ILE2) to (VAL106) ANTI-DNA ANTIBODY ED10 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2ojz:M (ILE2) to (VAL106) ANTI-DNA ANTIBODY ED10 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1ae6:L (ASP1) to (LEU106) IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01 | IMMUNOGLOBULIN, FAB FRAGMENT, HUMANISATION
4h0h:B (VAL141) to (ILE250) CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING 2D10 SCFV WITH PEPTIDE | MOLECULAR MIMICRY, SUGAR, IMMUNE SYSTEM
4h0i:A (VAL141) to (ILE250) CRYSTAL STRUCTURE OF SCFV-2D10 IN COMPLEX WITH METHYL ALPHA-D- MANNOPYRANOSIDE | SINGLE CHAIN ANTIBODY, MOLECULAR MIMICRY, ANTIGEN RECOGNITION, IMMUNE SYSTEM
3rvt:C (ILE2) to (MET106) STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP | IGG, ANTIBODY, DER F 1, DER P 1, IMMUNE SYSTEM
1nqb:A (ILE122) to (ILE231) TRIVALENT ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, MULTIVALENT ANTIBODY, DIABODY, DOMAIN SWAPPING, IMMUNOGLOBULIN
4hcr:L (ILE2) to (ILE111) CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659 | IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM
4x0k:L (ASP1) to (LEU106) ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE | ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM
4x0k:B (ILE2) to (LEU106) ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE | ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM
3s37:L (ILE2) to (ILE106) STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES | ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX
1bfv:L (ASP1) to (ILE111) MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI | IMMUNOGLOBULIN, FV FRAGMENT, STEROID HORMONE, FINE SPECIFICITY
3eyu:L (VAL2) to (GLU110) PFA1 FAB FRAGMENT COMPLEXED WITH ROR2(518-525) | FAB, AMYLOID, ALZHEIMER'S, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM
2bmk:A (ASP1) to (LEU106) FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE | CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM
1bln:C (ASP1) to (ALA109) ANTI-P-GLYCOPROTEIN FAB MRK-16 | IMMUNOGLOBULIN, IMMUNE SYSTEM
3s62:L (GLN1) to (LEU105) STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN | TYPICAL ANTIBODY FOLD, IMMUNE SYSTEM
1bqh:H (PRO2) to (GLN120) MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 | T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM
1bqh:K (PRO5) to (GLN120) MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 | T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM
4hpo:L (ASN1) to (THR105) CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 IN COMPLEX WITH V2 PEPTIDE | IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4hqq:L (ASN1) to (VAL106) CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 | IMMUNOGLOBULIN, IMMUNE SYSTEM
4xak:E (ILE2) to (ILE106) CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD | MERS-COV RBD, ANTIBODY M336, NEUTRALIZATION, IMMUNE SYSTEM
4xbg:B (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbg:F (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbg:K (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xbp:D (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE) | HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM
4xbp:F (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE) | HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM
3fct:A (VAL3) to (THR109) MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN | METAL CHELATASE, CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
2bx5:G (ASP1) to (ILE106) IS FR1 THE ANTIBODY'S ACHILLIES HEEL | IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1
2bx5:I (ILE2) to (ILE106) IS FR1 THE ANTIBODY'S ACHILLIES HEEL | IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1
1c12:A (ILE2) to (ILE106) INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE | ANTIBODY-ANTIGEN COMPLEX, SCFV FRAGMENT, CDRH3, MUSK ODORANT, ODORANT SPECIFICITY, IMMUNE SYSTEM
4xce:L (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP | 4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM
4xcf:L (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC) | 4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM
4xcn:L (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xcn:B (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xcn:D (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xcn:F (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xcn:I (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
4xcn:K (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM
2c1p:L (LEU2) to (LEU106) FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE | FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENANTIOSELECTIVE ANTIBODY, IMMUNOGLOBULIN DOMAIN
4i3r:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221 | ANTIBODY AFFINITY, ANTIBODY SPECIFICITY, BINDING SITES, HIV INFECTIONS, ANTIBODIES, HIV ENVELOPE PROTEIN GP120, AIDS VACCINES, AMINO ACID SEQUENCE, ANTIGENS, EPITOPES, HIV ANTIBODIES, CD4, SOMATIC MUTATION, SEQUENCE ENGINEERING, COMPLEMENTARITY DETERMINING REGIONS, IMMUNOGLOBULIN FAB FRAGMENTS, SERA, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3fmg:L (ILE2) to (LEU106) STRUCTURE OF ROTAVIRUS OUTER CAPSID PROTEIN VP7 TRIMER IN COMPLEX WITH A NEUTRALIZING FAB | ANTIBODY-ANTIGEN COMPLEX, CALCIUM DEPENDENT TRIMER, ANTIPARALLEL BETA-SANDWICH, JELLY ROLL, ALPHA-BETA-ALPHA SANDWICH, ROSSMANN FOLD, CAPSID PROTEIN, ENDOPLASMIC RETICULUM, GLYCOPROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
1cfv:L (ILE2) to (ILE111) MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI | FV FRAGMENT, STEROID HORMONE, FINE SPECIFICITY, IMMUNOGLOBULIN
1cgs:L (LEU2) to (LEU111) LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB | IMMUNOGLOBULIN
3fo1:L (GLU1) to (ILE111) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3fo1:A (GLU1) to (THR114) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3fo2:L (LEU2) to (THR114) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1op5:L (VAL2) to (ILE106) CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2 | DOMAIN-SWAPPED FAB 2G12 MAN9GLCNAC2 ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1opg:L (ASP1) to (ILE106) OPG2 FAB FRAGMENT | CELL ADHESION MOLECULE, IMMUNOGLOBULIN
4i77:L (ASP1) to (ILE106) LEBRIKIZUMAB FAB BOUND TO IL-13 | IMMUNOGLOBULIN, IMMUNE SYSTEM RECOGNITION, IMMUNE SYSTEM-CYTOKINE COMPLEX
1cr9:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 | ANTI-PRION ANTIBODY, FAB 3F4, IMMUNE SYSTEM
3stl:B (ILE2) to (ALA109) KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND | CADMIUM, TRANSMEMBRANE PROTEIN, ION CHANNEL, KCSA POTASSIUM CHANNEL, INACTIVATION, MEMBRANE PROTEIN
4xny:L (TYR1) to (ILE106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4xp5:L (ASN2) to (MET107) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO COCAINE ANALOGUE-RTI55 | INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX
1dba:L (VAL2) to (ILE106) THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX | IMMUNOGLOBULIN
1dbj:L (VAL2) to (ILE106) MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY | IMMUNOGLOBULIN
1dbk:L (MET4) to (ILE106) MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY | IMMUNOGLOBULIN
1dbm:L (VAL2) to (ILE106) MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY | IMMUNOGLOBULIN
3g5y:A (ILE2) to (ALA109) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
3g5z:A (ILE2) to (ILE106) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
4imk:C (GLY3) to (VAL107) UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2 | ANTIGEN-BINDING FRAGMENT (FAB), HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM
1pew:B (ASN1) to (VAL106) HIGH RESOLUTION CRYSTAL STRUCTURE OF JTO2, A MUTANT OF THE NON- AMYLOIDOGENIC LAMBA6 LIGHT CHAIN, JTO | BETA SHEET, IMMUNE SYSTEM
3t3m:L (ILE2) to (ILE106) A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS | INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET
3t3p:L (ILE2) to (ILE106) A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS | INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET
4xxd:D (VAL2) to (ILE106) CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB | FAB, AMYLOID-BETA, IMMUNE SYSTEM
1dqq:C (ILE2) to (ILE106) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63 | ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
1dsf:L (VAL2) to (LEU106) THE CRYSTAL STRUCTURE OF THE DISULFIDE-STABILIZED FV FRAGMENT OF ANTICANCER ANTIBODY B1: CONFORMATIONAL INFLUENCE OF AN ENGINEERED DISULFIDE BOND | MONOCLONAL ANTIBODY, ANTITUMOR, IMMUNOGLOBULIN
3gkz:A (ILE142) to (ILE247) CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX METHAMPHETAMINE | THERAPEUTIC ANTIBODY, METHAMPHETAMINE, AMPHETAMINE, MDMA, IGG, IMMUNE SYSTEM
3gm0:A (ILE142) to (ILE247) ANTI-METHAMPHETAMINE SINGLE CHAIN FV IN COMPLEX WITH MDMA | ANTI-METHAMPHETAMINE ANTIBODY, SINGLE CHAIN FV, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
3gnm:L (VAL2) to (ALA114) THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT | ANTIBODY, IMMUNOGLOBULIN, JAA-F11, THOMPSON-FRIEDENREICH ANTIGEN, IMMUNE SYSTEM
3go1:L (SER1) to (VAL106) CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN | HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM
1e6j:L (GLU1) to (ILE104) CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5 | HIV CAPSID PROTEIN (P24), P24, FAB, HIV-1, VIRUS ASSEMBLY, CAPSID, CA, ANTIGEN, ANTIBODY, PROTEIN-PROTEIN INTERACTIONS, VIRAL PROTEIN
4jdt:L (VAL3) to (VAL100) CRYSTAL STRUCTURE OF CHIMERIC GERM-LINE PRECURSOR OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV-1 | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4jfx:A (ILE2) to (ILE106) STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE | IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
4yc2:C (VAL4) to (VAL106) CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32. | ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ydi:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF BROAD AND POTENTLY NEUTRALIZING VRC01-CLASS ANTIBODY Z258-VRC27.01, ISOLATED FROM HUMAN DONOR Z258, IN COMPLEX WITH HIV-1 GP120 FROM CLADE A STRAIN Q23.17 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4ye4:L (VAL2) to (LEU113) CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY HJ16 IN COMPLEX WITH HIV-1 GP120 | HIV1, ANTIBODY, GP120, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1qok:A (VAL164) to (LEU266) MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY | IMMUNOGLOBULIN, SINGLE-CHAIN FV, ANTI-CARCINOEMBRYONIC ANTIGEN
4jpv:L (ASP1) to (LEU106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, CD4-BINDING SITE, 3BNC117, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4jr9:L (LEU3) to (ALA108) CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK | TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4yhp:D (TYR2) to (VAL107) CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM
4yhz:L (LEU4) to (THR110) CRYSTAL STRUCTURE OF 304M3-B FAB IN COMPLEX WITH H3K4ME3 PEPTIDE | ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K4ME3, IMMUNE SYSTEM
2uud:L (GLN1) to (ILE106) CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN | SCFV, ANTIBODY, IMMUNOGLOBULIN, 2-PHENYL-5-OXAZOLONE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1f8t:L (VAL2) to (ILE106) FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL, IMMUNE SYSTEM
1f90:L (VAL2) to (ILE106) FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, ANTIGENIC PEPTIDE, IMMUNE SYSTEM
2eh8:L (GLN3) to (THR109) CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE | CRYSTAL STRUCTURE, HEPATITIS B VIRUS, HUMANIZED ANTIBODY, MONOCLONAL ANTIBODY, NEUTRALIZATION, PRES1, IMMUNE SYSTEM
3u7w:L (ILE2) to (VAL104) CRYSTAL STRUCTURE OF NIH45-46 FAB | IG FOLD, ANTIBODY, HIV GP120, IMMUNE SYSTEM
4jzo:B (TYR2) to (THR108) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1fl6:L (GLU1) to (THR109) THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4 | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
1fl6:A (GLU1) to (THR109) THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4 | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
1rfd:L (ILE2) to (ALA109) ANTI-COCAINE ANTIBODY M82G2 | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
1rmf:L (VAL2) to (ILE111) STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
3uo1:L (VAL2) to (ILE110) STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN | IG-FOLD, 3,10-HELIX, IMMUNE SYSTEM
1g7l:A (ASP1) to (ILE106) CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92S) | HYDROLASE INHIBITOR/HYDROLASE
1rzi:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:C (ASP1) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
3utz:A (VAL2) to (ILE111) ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL | STRUCTURAL GENOMICS, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, FAB DOMAIN, IMMUNE SYSTEM
4z7n:L (ILE2) to (ILE106) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4z7o:L (ILE2) to (ILE106) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
4z7q:L (ILE2) to (ILE106) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
3uyr:L (ASP1) to (ILE110) STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN | IG-FOLD 3,10 HELIX, IMMUNE SYSTEM
3v4p:L (VAL2) to (ILE111) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 | CELL ADHESION, MADCAM-1, MEMBRANE
3v4p:N (VAL2) to (ILE111) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 | CELL ADHESION, MADCAM-1, MEMBRANE
3v4u:L (VAL2) to (ILE110) STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN | IG-FOLD, 3-10 HELIX, IMMUNE SYSTEM
3v52:L (ASP1) to (ILE110) STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN | IG DOMAIN, 3-10 HELIX, IMMUNE SYSTEM
2fx7:L (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
2fx8:M (ILE2) to (VAL106) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM
2g2r:L (VAL2) to (ALA109) GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE) | IMMUNOGLOBULIN,GREEN-FLUORESCENT ANTIBODY, STILBENE-COMPLEX, IMMUNE SYSTEM
2g2r:A (VAL2) to (LEU106) GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE) | IMMUNOGLOBULIN,GREEN-FLUORESCENT ANTIBODY, STILBENE-COMPLEX, IMMUNE SYSTEM
3vg9:B (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION | 7 TRANSMEMBRANE RECEPTOR, SIGNAL TRANSDUCTION, SIGNALING PROTEIN
3vi4:E (ILE2) to (LEU111) CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE | BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX
2gjz:L (LEU2) to (ILE106) STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1) | IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM
2gjz:A (LEU2) to (ILE106) STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1) | IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM
2gk0:A (VAL3) to (ALA109) STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2 | IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM
3iet:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN | GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM
3ifn:L (ASP1) to (LEU111) X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX | ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM
2gsi:E (ILE2) to (ILE106) CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE | FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM
4las:L (ILE2) to (ILE106) CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE | METHAMPHETAMINE, ANTI-METHAMPHETAMINE ANTIBODY, THERAPEUTIC ANTIBODY, SCFV, IMMUNE SYSTEM
2w60:B (VAL2) to (LEU111) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 | ANTIBODY ANTI-CITRULLIN, ARTHRITIS, IMMUNE SYSTEM
2w65:B (VAL2) to (LEU111) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE | ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM
2w65:D (VAL2) to (LEU111) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE | ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM
1hez:A (GLN3) to (ILE106) ANTIBODY-ANTIGEN COMPLEX | ANTIBODY, SUPERANTIGEN
2h9g:A (ASP1) to (ILE106) CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5) | PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, AGONISTS, IMMUNE SYSTEM- APOPTOSIS COMPLEX
2h9g:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5) | PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, AGONISTS, IMMUNE SYSTEM- APOPTOSIS COMPLEX
1tpx:C (VAL2) to (ILE106) OVINE RECOMBINANT PRP(114-234), ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY | PRION, ANTIBODY, UNKNOWN FUNCTION
3vrl:F (ASP1) to (ILE106) CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB | HIV-1 CAPSIDE P24, CAPSID PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1tzh:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF | PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM
4lqf:L (VAL2) to (ILE112) STRUCTURE OF MURINE IGG2B A2C7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.3 ANGSTROMS | IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2B, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM
4lss:L (VAL3) to (VAL106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120 | ANTIBODY ANTIGEN COMPLEX, NEUTRALIZING ANTIBODY VRC01, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4lst:L (LEU4) to (VAL106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120 | NEUTRALIZING ANTIBODY VRC01, HIV ENVELOPE GLYCOPROTEIN GP120, ANTIBODY ANTIGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3w13:D (ILE2) to (ILE111) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2, ALPHACT PEPTIDE(693-719) AND FAB 83-7 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN ANALOGUE, HORMONE RECEPTOR-HORMONE-IMMUNE SYSTEM COMPLEX
3w14:D (ILE2) to (ILE106) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX
4lu5:M (VAL2) to (ALA114) STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS | IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM
4lvh:L (ILE1) to (GLU108) INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ | INFLUENZA VIRUS, IMMUNE SYSTEM, HEMAGGLUTININ, ANTIBODY
1uac:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH TURKEY WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, MUTANT, ANTI-LYSOZYME ANTIBODY, IMMUNE SYSTEM/HYDROLASE COMPLEX
1i9j:L (VAL3) to (ILE111) TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT | FAB FRAGMENT, ANTI-TESTOSTERONE, RECOMBINANT, MONOCLONAL, TESTOSTERONE, IMMUNE SYSTEM
1ic5:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD99A)-HEN LYSOZYME COMPLEX | ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, ANTI-HEN EGG WHITE LYSOZYME ANTIBODY, PROTEIN BINDING/HYDROLASE COMPLEX
1igf:L (LEU3) to (ILE106) CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | IMMUNOGLOBULIN
2i5y:Q (ASP1) to (ILE106) CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5a7x:M (GLN3) to (VAL106) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:O (GLN3) to (VAL106) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a7x:Q (GLN3) to (VAL106) NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN
5a8h:E (GLN3) to (VAL106) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:K (GLN3) to (VAL106) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
5a8h:Q (GLN3) to (VAL106) CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195 | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS
4m6n:L (SER2) to (VAL110) CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
3wbd:A (VAL2) to (GLU110) CRYSTAL STRUCTURE OF ANTI-POLYSIALIC ACID ANTIBODY SINGLE CHAIN FV FRAGMENT (MAB735) COMPLEXED WITH OCTASIALIC ACID | BETA-SANDWICH, IMMUNOGLOBULIN FOLD, SINGLE CHAIN FV FRAGMENT, ANTI- POLYSIALIC ACID, ALPHA2-8 LINKED POLYSIALIC ACID, IMMUNE SYSTEM
3wbd:B (VAL2) to (ILE111) CRYSTAL STRUCTURE OF ANTI-POLYSIALIC ACID ANTIBODY SINGLE CHAIN FV FRAGMENT (MAB735) COMPLEXED WITH OCTASIALIC ACID | BETA-SANDWICH, IMMUNOGLOBULIN FOLD, SINGLE CHAIN FV FRAGMENT, ANTI- POLYSIALIC ACID, ALPHA2-8 LINKED POLYSIALIC ACID, IMMUNE SYSTEM
4ma1:L (ILE2) to (LEU106) UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB | CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM
2ipu:L (VAL2) to (LEU106) PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE | WWDDD, CDR, ABETA, IMMUNE SYSTEM
3j42:H (VAL1003) to (ILE1106) OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY | DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX
3j42:J (VAL1003) to (ILE1106) OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY | DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX
3j42:L (VAL1003) to (ILE1106) OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY | DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX
5ayu:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV | IMMUNE SYSTEM
4n1e:E (ILE2) to (ILE106) STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION | IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, ANTIGEN-RECEPTOR INTERACTION, IG-FOLD, IMMUNE SYSTEM-HYDROLASE COMPLEX
3zdx:L (ILE2) to (ILE106) INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX | CELL ADHESION-IMMUNE SYSTEM COMPLEX
3jau:L (ASP1) to (ILE111) THE CRYOEM MAP OF EV71 MATURE VIRON IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY D5 | ENTEROVIRUS 71(EV71), VIRUS-ANTIBODY COMPLEX, BIVALENT BINDING, HIGH RESOLUTION CRYO-EM, VIRUS-IMMUNE SYSTEM COMPLEX
4n9g:B (GLN3) to (ILE106) CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9 | ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM
4n9g:F (GLN3) to (ILE106) CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9 | ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM
4n9g:N (GLN3) to (ILE106) CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9 | ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM
4ncc:L (VAL3) to (ILE105) NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS | IMMUNOGLOBIN, ANTIBODY, MURINE NOROVIRUS, IMMUNE SYSTEM
4ncc:1 (VAL3) to (ILE105) NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS | IMMUNOGLOBIN, ANTIBODY, MURINE NOROVIRUS, IMMUNE SYSTEM
4nhc:L (ILE2) to (VAL106) CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41. | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, 4E10 FAB, ANTIBODY-EPITOPE COMPLEX, GP41 HIV-1, HYDROCARBON STAPLE, IMMUNE SYSTEM
4nhg:L (VAL2) to (ILE106) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhg:K (VAL2) to (ILE106) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhg:C (VAL2) to (ILE106) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhg:B (VAL2) to (ILE106) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhg:G (VAL2) to (ILE106) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nhg:F (VAL2) to (ILE106) CRYSTAL STRUCTURE OF 2G12 IGG DIMER | IG FOLD, ANTIBODY, IMMUNE SYSTEM
4nkd:B (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkd:D (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkd:F (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkd:H (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkm:B (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkm:D (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkm:F (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nkm:H (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX
4nm8:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNOGLOBULIN'
4nm8:M (ASP1) to (ILE106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNOGLOBULIN'
1kfa:M (VAL3) to (ILE111) CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4 | IMMUNOGLOBUILN FOLD, IMMUNE SYSTEM
1kn2:L (ILE2) to (ILE106) CATALYTIC ANTIBODY D2.3 COMPLEX | ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM
1kn4:L (ILE2) to (ILE106) CATALYTIC ANTIBODY D2.3 COMPLEX | ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM
2mcg:1 (LEU4) to (VAL109) THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS | IMMUNOGLOBULIN
4nug:L (VAL3) to (LEU106) CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT151 | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE
4nuj:A (ILE2) to (LEU106) CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT152 | IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE
5c7k:F (ASP1) to (VAL106) CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195 | HIV-1, SOSIP, PGT128, 8ANC195, IMMUNE SYSTEM
2nlj:A (ILE2) to (ILE106) POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL | VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN
1xf4:A (LEU2) to (LEU106) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM
1xgp:A (ILE2) to (ILE106) STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A RESOLUTION, Y33A MUTANT, IMMUNE SYSTEM
1xgq:A (ILE2) to (ILE106) STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A RESOLUTION, Y33V MUTANT, IMMUNE SYSTEM
1xgu:A (ILE2) to (ILE106) STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33F MUTANT, IMMUNE SYSTEM
1xgy:M (ILE2) to (LEU106) CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L | META-I, RHODOPSIN, FAB, IGG, K42-41L, PHAGE DISPLAY, ANTIBODY, IMMUNOGLOBULIN, ANTIBODY IMPRINTING, PEPTIDE MIMETICS, IMMUNE SYSTEM
4oaw:C (ASP1) to (ILE106) FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4ocs:L (VAL3) to (VAL106) CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY | FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM
5cip:L (GLU1) to (VAL106) CRYSTAL STRUCTURE OF UNBOUND 4E10 | BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM
5cip:B (ILE2) to (VAL106) CRYSTAL STRUCTURE OF UNBOUND 4E10 | BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM
4odx:B (GLU1) to (ILE106) 4E10 GERMLINE ENCODED PRECURSOR NO.7 IN COMPLEX WITH EPITOPE SCAFFOLD T117 | HIV, 4E10, GEP, GERMLINE, ANTIBODY, FV, IMMUNOGLOBULIN, 4E10 EPITOPE, IMMUNE SYSTEM
4odx:L (GLU1) to (ARG108) 4E10 GERMLINE ENCODED PRECURSOR NO.7 IN COMPLEX WITH EPITOPE SCAFFOLD T117 | HIV, 4E10, GEP, GERMLINE, ANTIBODY, FV, IMMUNOGLOBULIN, 4E10 EPITOPE, IMMUNE SYSTEM
5cjx:C (GLN3) to (VAL106) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER | HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjx:E (GLN3) to (VAL106) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER | HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjx:L (GLN3) to (VAL106) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER | HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cp7:C (ASP1) to (ILE111) CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES | ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM
5cp7:E (VAL2) to (ALA114) CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES | ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM
4ojf:L (VAL2) to (ILE106) HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8 | AMYLOID, BAPINEUZUMAB, 3D6, ALZHEIMER'S DISEASE, IMMUNOGLOBULIN, IMMUNOTHERAPY, AMYLOID BETA, IMMUNE SYSTEM
4olv:L (VAL3) to (VAL106) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54F IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54F, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4olw:L (VAL3) to (VAL106) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54H IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54H, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4om1:L (ILE2) to (VAL106) CRYSTAL STRUCTURE OF ANTIBODY VRC07-I30Q, G54W, S58N IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-I30Q, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ong:L (VAL2) to (ILE111) FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40 | ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM
5cus:N (SER2) to (VAL109) CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX | ERBB3, ANTIBODY, TRANSFERASE
4ouu:L (VAL2) to (ILE111) ANTI-MT1-MMP MONOCLONAL ANTIBODY | STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IMMUNOGLOBULIN FOLD, HYDROLASE
4ouu:A (VAL2) to (ILE111) ANTI-MT1-MMP MONOCLONAL ANTIBODY | STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IMMUNOGLOBULIN FOLD, HYDROLASE
1mce:B (ALA3) to (VAL109) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
1mch:B (ALA3) to (VAL109) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
1mcj:A (LEU4) to (GLY111) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
1mcn:B (PRO1) to (VAL109) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN, IMMUNE SYSTEM
1mcs:B (ALA3) to (VAL109) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
1mh5:A (ILE2) to (LEU106) THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM
1mh5:L (ASP1) to (LEU106) THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG | CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM
5d1q:A (ILE2) to (ILE106) ISDB NEAT2 BOUND BY CLONE D2-06 | ISDB NEAT2, IGVH1-69, GERMLINE ENCODED, IMMUNE SYSTEM
5d1x:D (GLU1) to (ILE106) ISDB NEAT2 BOUND BY D4-30 | ISDB, NEAT2, GERMLINE ENCODED, IMMUNE SYSTEM
5d2l:I (LEU2) to (GLN113) CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2 | TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM
4p3c:L (ASP1) to (ILE111) MT1-MMP:FAB COMPLEX (FORM I) | IMMUNE SYSTEM
4p3d:B (ASP1) to (ILE111) MT1-MMP:FAB COMPLEX (FORM II) | IMMUNE SYSTEM
4p3d:L (ASP1) to (ILE111) MT1-MMP:FAB COMPLEX (FORM II) | IMMUNE SYSTEM
4p9h:L (ASP1) to (VAL106) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2 | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
1yee:L (ILE2) to (ILE106) STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5) | CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE
1yeg:L (ILE2) to (ILE106) STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT | CATALYTIC ANTIBODY
1yei:L (VAL3) to (ILE106) CATALYTIC ANTIBODY D2.3 COMPLEX | CATALYTIC ANTIBODY D2.3 COMPLEX, IMMUNE SYSTEM
1yej:L (ILE2) to (ILE106) CATALYTIC ANTIBODY COMPLEX | ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM
1yek:L (ILE2) to (ILE106) CATALYTIC ANTIBODY D2.3 COMPLEX | ABZYME, REACTION PRODUCT, IMMUNE SYSTEM
4pb0:L (VAL2) to (ILE106) STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53 | ANTIBODY, IMMUNE SYSTEM
5d93:B (VAL3) to (LEU105) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY | ENZYME, INHIBITOR, THIOREDOXIN FOLD, ANTIBODY, OXIDOREDUCTASE
4pb9:L (ASP1) to (VAL106) STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64 | ANTIBODY, IMMUNE SYSTEM
3kym:G (ASP1) to (ILE106) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:I (ASP1) to (ILE106) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
1yyl:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4plj:L (ILE2) to (ILE106) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUME SYSTEM COMPLEX
4plj:C (ILE2) to (ILE106) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUME SYSTEM COMPLEX
5dlm:L (LEU3) to (ALA114) COMPLEX OF INFLUENZA M2E AND ANTIBODY | COMPLEX, ANTIBODY, EXTRACELLULAR DOMAIN, IMMUNE SYSTEM
1z3g:L (ILE2) to (ALA108) CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 | 2A8 FAB, PVS25, IMMUNE SYSTEM-CELL ADHESION COMPLEX
1z3g:M (VAL3) to (ALA108) CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 | 2A8 FAB, PVS25, IMMUNE SYSTEM-CELL ADHESION COMPLEX
3lh2:M (ILE2) to (VAL107) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX | EPITOPE-SCAFFOLD, IMMUNE SYSTEM
5drx:B (ILE2) to (ILE112) CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL240 | IMMUNOGLOBULIN FOLD, B CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX
1zwi:B (ILE2) to (ALA109) STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL | X-RAY CRYSTALLOGRAPHY; POTASSIUM ION CHANNEL; TRANSMEMBRANE PROTEIN, IMMUNE SYSTEM-ION TRANSPORT COMPLEX
3auv:C (GLN14) to (ILE117) PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE | SC-DSFV (DISULFIDE-STABILIZED SCFV), SCFV, MONOVALENT ANTIBODY, VEGF, ANTIBODY ENGINEERING, IMMUNE SYSTEM
25c8:L (VAL3) to (ILE106) CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX | CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION
4qex:L (ASN1) to (ALA109) CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217 | DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM
4qex:M (ASN1) to (ALA109) CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217 | DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM
3bd5:A (LEU160) to (ILE270) CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS | BETA SANDWICH, METAL COMPLEX, IMMUNE SYSTEM
3mlr:L (TYR2) to (VAL109) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mls:M (TYR2) to (VAL109) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, MIMOTOPE, IMMUNE SYSTEM
3mls:N (TYR2) to (VAL109) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, MIMOTOPE, IMMUNE SYSTEM
3mlt:D (TYR2) to (VAL109) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlt:G (TYR2) to (VAL109) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
4bh8:A (ASP1) to (ILE106) CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE GDPRPSYISHLL | IMMUNE SYSTEM, GERMLINE ANTIBODY, ANTIBODY POLYSPECIFICTY
4qt5:A (LEU2) to (ALA109) CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR | GRAVES DISEASE, ANTIBODY, TSH RECEPTOR, THYROID, IMMUNE SYSTEM
4qxg:L (VAL3) to (ILE107) ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY | IGV AND IGC TYPE FOLDS, ANTIGEN BINDING, IFNAR1, INTERFERON ALPHA RECEPTOR 1, IMMUNE SYSTEM
5f3h:D (ILE2) to (ILE106) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
4qxu:L (ASP1) to (ILE111) NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY | STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IGG FOLD, IMMUNE SYSTEM
4r0l:L (ASP1) to (ILE107) ANTI-CANINE CD28 ANTIBODY, 1C6, BOUND CANINE CD28 | IMMUNOGLOBULIN, T-CELL ACTIVATION, CD28, 1C6, IMMUNE SYSTEM
5fgb:A (TYR2) to (THR109) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4 | FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, IMMUNE SYSTEM
5fgb:B (TYR2) to (THR109) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4 | FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, IMMUNE SYSTEM
5fhb:L (TYR2) to (VAL106) CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100 | IG DOMAIN, FAB, IMMUNE SYSTEM
4r7d:D (ILE2) to (ILE106) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7d:H (ILE2) to (ILE106) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7d:L (ILE2) to (ILE106) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:H (VAL3) to (ILE106) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r9y:M (GLN28) to (ALA134) CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4 | KKO, PF4, HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM-CYTOKINE COMPLEX
3nfp:B (ILE2) to (VAL105) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX
3nfp:L (ILE2) to (VAL105) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX
3ngb:C (VAL3) to (VAL106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3ngb:K (VAL3) to (VAL106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3nif:L (ILE2) to (ILE106) THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING | INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX
3nig:L (ILE2) to (ILE106) THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING | INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-IMMUNE SYSTEM COMPLEX, CELL ADHESION-BLOOD CLOTTING COMPLEX
3nn8:H (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5 | BETA BARREL, ANTIBODY FRAGMENT, IMMUNOGLOBULIN, IMMUNE SYSTEM
5fuu:L (ASP1) to (LEU106) ECTODOMAIN OF CLEAVED WILD TYPE JR-FL ENVDCT TRIMER IN COMPLEX WITH PGT151 FAB | VIRAL PROTEIN, HIV-1, ENV, PGT151, BROADLY NEUTRALIZING ANTIBODY
5fv1:M (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HVEGF IN COMPLEX WITH VK DOMAIN ANTIBODY | IMMUNE SYSTEM, VEGF, DOMAIN ANTIBODY, VASCULAR ENDOTHELIAL GROWTH FACTOR
4rqs:C (ASP1) to (ILE106) CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB | IMMUNOGLOBULIN FOLD, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
3o2w:L (LEU2) to (THR109) CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG | IGG ANTIBODY FAB, IMMUNE SYSTEM
4tnw:h (GLN1) to (LEU109) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4trp:L (VAL2) to (LEU112) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | ANTIBODY, IMMUNE SYSTEM
5gir:L (ILE2) to (MET106) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE | FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM
5gir:B (ILE2) to (MET106) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE | FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM
4tuj:B (VAL3) to (LEU112) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | ANTIBODY, NEUROBLASTOMA, IMMUNE SYSTEM
4d3c:L (LEU2) to (THR110) CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68. | PROTEIN BINDING
5grz:G (ILE125) to (ILE230) CRYSTAL STRUCTURE OF DISULFIDE-BONDED DIABODY | DIABODY, ANTIBODY FRAGMENT, DISULFIDE BOND, IMMUNE SYSTEM
5hdb:L (ILE2) to (ILE106) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054 | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX, INTEGRIN INHIBITOR, RGD MIMETICS
5hhx:L (PHE2) to (VAL106) INHIBITING COMPLEX IL-17A AND IL-17RA INTERACTIONS WITH A LINEAR PEPTIDE | IL-17, INFLAMMATION, INHIBITOR, COMPLEX CRYSTAL STRUCTURE, IMMUNE SYSTEM-INHIBITOR COMPLEX
4dtg:L (ILE2) to (THR114) HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL | ANTIBODY, INHIBITOR, BLOOD COAGULATION, BLOOD CLOTTING INHIBITOR- IMMUNE SYSTEM COMPLEX
5i17:A (ILE2) to (ILE107) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i6x:C (ASP21) to (ALA129) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE | MEMBRANE PROTEIN
5i6z:C (ASP21) to (ALA129) X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER | MEMBRANE PROTEIN
5i71:C (ASP21) to (ALA129) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE | MEMBRANE PROTEIN
5i73:C (ASP21) to (ALA129) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES | MEMBRANE PROTEIN
5i75:C (ASP21) to (ALA129) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE | MEMBRANE PROTEIN
5i9q:C (GLN3) to (LEU99) CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
4uuj:B (ILE2) to (ILE106) POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM | IMMUNE SYSTEM-METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT, POTASSIUM CHANNEL
4uv7:L (ILE2) to (ILE111) THE COMPLEX STRUCTURE OF EXTRACELLULAR DOMAIN OF EGFR AND GC1118A | TRANSFERASE, RECEPTOR TYROSINE KINASE, ANTIBODY
5iwl:B (ILE124) to (ILE233) CD47-DIABODY COMPLEX | RECEPTOR, DIABODY, COMPLEX, CELL ADHESION
5iwl:A (ILE124) to (ILE233) CD47-DIABODY COMPLEX | RECEPTOR, DIABODY, COMPLEX, CELL ADHESION
3qeh:B (VAL3) to (ILE105) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
3qeh:D (ILE2) to (ILE105) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
3qeh:H (ILE2) to (ILE105) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
4f37:K (ILE2) to (LEU111) STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE | AMYLOID-BETA, ALZHEIMER'S DISEASE, IMMUNE SYSTEM
3qum:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY | KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM
3raj:L (ILE1) to (ILE104) CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7 | CD38, ADP-RIBOSYL CYCLASE, CYCLIC ADP-RIBOSE, X-CRYSTALLOGRAPHY, CALCIUM SIGNALING, AGONISTIC ANTIBODY, HB7, HYDROLASE-IMMUNE SYSTEM COMPLEX
5jof:D (GLU1) to (VAL106) CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT. | HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM
5jue:L (VAL2) to (ILE106) CRYSTAL STRUCTURE OF UIC2 FAB | ANTIBODY FAB, P-GLYCOPROTEIN, TRANSPORT INHIBITION, IMMUNE SYSTEM
5kan:I (ASP1) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5kan:K (ASP1) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5ken:H (ILE2) to (ILE106) EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6 | EBOLA VIRUS SURFACE GLYCOPROTEIN, THERAPEUTIC ANTIBODY COCKTAIL, ZMAPP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gmt:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 | FAB, FRAGMENT ANTIGEN BINDING, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4gmt:M (ASP1) to (ILE106) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 | FAB, FRAGMENT ANTIGEN BINDING, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
4gqp:H (ILE1002) to (ILE1106) STRUCTURE BASED DESIGN OF SUB-NANOMOLAR AFFINITY ANTI-METHAMPHETAMINE SINGLE CHAIN ANTIBODIES. | ANTIBODY METH COMPLEX, IMMUNOGLOBULIN FOLD, ANTI-METH SINGLE CHAIN ANTIBODY, FREE METH CONCENTRATION, METHAMPHETAMINE, VASCULATURE, IMMUNE SYSTEM
5l88:L (ILE2) to (MET106) AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSILATED, CRYSTAL FORM I, NON-PARSIMONIOUS MODEL | AFAMIN ANTIBODY, FAB FRAGMENT, IGG1-KAPPA, LIGHT CHAIN GLYCOSILATION, IMMUNE SYSTEM
2ai0:N (LEU3) to (SER111) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III | IMMUNE SYSTEM
1a4j:L (LEU2) to (ILE111) DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
1a4j:A (LEU2) to (ILE111) DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
2atk:B (ILE2) to (ALA109) STRUCTURE OF A MUTANT KCSA K+ CHANNEL | K+ CHANNEL, MUTANT KCSA, PROTEIN-ANTIBODY FAB COMPLEX, IMMUNE SYSTEM- ION TRANSPORT COMPLEX
1ar1:D (ILE2) to (ILE107) STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT | COMPLEX (OXIDOREDUCTASE/ANTIBODY), ELECTRON TRANSPORT, TRANSMEMBRANE, CYTOCHROME OXIDASE, ANTIBODY COMPLEX
3eo1:D (THR2) to (ILE107) STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3 | ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX
3eo1:J (THR2) to (ILE107) STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3 | ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX
1bwm:A (GLN302) to (VAL414) A SINGLE-CHAIN T CELL RECEPTOR | IMMUNOGLOBULIN, IMMUNORECEPTOR, IMMUNE SYSTEM
4xcy:I (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG) | 4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL
4xcy:K (GLU1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG) | 4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL
2cgr:L (LEU2) to (LEU111) LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB | IMMUNOGLOBULIN
4ybq:C (VAL5) to (ILE113) RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM | SUGAR TRANSPORTER, MAJOR FACILITATOR SUPERFAMILY, TRANSPORT PROTEIN- IMMUNE SYSTEM COMPLEX
1riu:L (ILE2) to (ALA109) ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE | ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM
1g7j:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92H) | HYDROLASE INHIBITOR/HYDROLASE
1g7m:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92V) | HYDROLASE INHIBITOR/HYDROLASE
2vh5:L (ILE4) to (GLU107) CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX | IMMUNOGLOBULIN DOMAIN, SIGNALING PROTEIN/IMMUNE SYSTEM, METHYLATION, PRENYLATION, LIPOPROTEIN, GTP-BINDING, SIGNAL TRANSDUCTION, NUCLEOTIDE- BINDING, DISEASE MUTATION, NUCLEOTIDE-BINDING, IMMUNE SYSTEM, MEMBRANE, ONCOGENE, ANTIBODY, PALMITATE, INTRABODY, PROTO-ONCOGENE, CANCER THERAPY, GOLGI APPARATUS
3hpl:B (ASP1) to (ALA109) KCSA E71H-F103A MUTANT IN THE CLOSED STATE | KCSA, E71H, F103A, CLOSED, INACTIVATION, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, IMMUNE SYSTEM-METAL TRANSPORT COMPLEX
3v4v:N (VAL2) to (ILE111) CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376 | CELL ADHESION, MADCAM-1, MEMBRANE
3i50:L (GLN1) to (LEU106) CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB | ANTIBODY, FAB, VIRUS, ENVELOPE, IMMUNOGLOBULIN, FUSION LOOP, DISULFIDE BOND, ENVELOPE PROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2h2s:D (ASP1) to (ILE105) CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN- | CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT
3iu3:B (GLN1) to (ILE103) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM
3iu3:L (GLN1) to (ILE103) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM
4zyp:G (GLN3) to (THR109) CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION
4zyp:I (ASP1) to (ILE106) CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN | IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION
1it9:L (VAL3) to (ILE110) CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A | IMMUNOGLOBULIN, FAB, ANTI_FAS, AGONISTIC_ANTIBODY, APOPTOSIS, ANTIBODY_HUMANIZATION, IMMUNE SYSTEM
1vfb:A (ILE2) to (ILE106) BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION | IMMUNOGLOBULIN/HYDROLASE(O-GLYCOSYL)
3x3f:L (ILE2) to (ILE106) TRAIL-R2 EXTRACELLULAR REGION COMPLEXED TO A FAB FRAGMENT FROM HUMAN AGONIST ANTIBODY KMTR2 | TRAIL-R2, AGONIST ANTIBODY, APOPTOSIS-IMMUNE SYSTEM COMPLEX
4nko:A (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, HEXA-HISTIDINE BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM-CHAPERONE COMPLEX
4nko:C (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, HEXA-HISTIDINE BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM-CHAPERONE COMPLEX
1xgt:A (ILE2) to (ILE106) STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33L MUTANT, IMMUNE SYSTEM
4oly:L (VAL3) to (VAL106) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54R IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54R, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4p9m:L (GLN3) to (VAL106) CRYSTAL STRUCTURE OF 8ANC195 FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
1yef:L (VAL3) to (ILE106) STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE | CATALYTIC ANTIBODY
1n4x:L (ILE2) to (ILE111) STRUCTURE OF SCFV 1696 AT ACIDIC PH | IMMUNOGLOBULIN, IMMUNE SYSTEM
1n4x:M (ILE2) to (ILE111) STRUCTURE OF SCFV 1696 AT ACIDIC PH | IMMUNOGLOBULIN, IMMUNE SYSTEM
4plk:L (ILE2) to (ILE106) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4plk:K (ILE2) to (ALA109) HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12 | COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3lex:B (VAL3) to (ILE106) 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41 | HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN
5dum:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 65C6 | INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM
3mlv:L (TYR2) to (LEU110) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3dmm:C (ALA4) to (LEU119) CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX | T CELL CO-RECEPTOR CD8AB MHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, ENVELOPE PROTEIN, ALTERNATIVE SPLICING, POLYMORPHISM, IMMUNE SYSTEM
3piq:B (TYR2) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
5i74:C (ASP21) to (ALA129) X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE | MEMBRANE PROTEIN
4fqq:A (TYR3) to (VAL106) CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM
5kzc:L (ILE2) to (VAL106) CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01 | HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM
5kzc:D (VAL3) to (VAL106) CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01 | HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM